Disrupting the normal function of the m6A-related enzyme complex, which is vital for cell function, may lead to the formation of solid tumors as well as confer drug resistance in cancer, pointing to the fundamental role of m6A methylation in carcinogenesis [23]. The gene discussed is METTL3; the disease is cancer.